First Light Asset Management as of June 30, 2014
Portfolio Holdings for First Light Asset Management
First Light Asset Management holds 68 positions in its portfolio as reported in the June 2014 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
AtriCure (ATRC) | 6.0 | $8.9M | 484k | 18.38 | |
Akorn | 4.7 | $6.9M | 208k | 33.25 | |
NeoGenomics (NEO) | 4.6 | $6.8M | 2.0M | 3.32 | |
Spectranetics Corporation | 4.4 | $6.5M | 285k | 22.88 | |
IGI Laboratories | 4.3 | $6.3M | 1.2M | 5.31 | |
Enzo Biochem (ENZ) | 3.9 | $5.8M | 1.1M | 5.25 | |
RTI Biologics | 3.8 | $5.7M | 1.3M | 4.35 | |
Array BioPharma | 3.2 | $4.7M | 1.0M | 4.56 | |
Ligand Pharmaceuticals In (LGND) | 3.1 | $4.6M | 74k | 62.29 | |
Harvard Bioscience (HBIO) | 3.1 | $4.6M | 1.0M | 4.55 | |
Omnicell (OMCL) | 2.9 | $4.3M | 151k | 28.71 | |
Tearlab Corp | 2.9 | $4.3M | 874k | 4.87 | |
Lannett Company | 2.8 | $4.1M | 84k | 49.62 | |
Streamline Health Solutions (STRM) | 2.7 | $4.0M | 827k | 4.80 | |
Vocera Communications | 2.4 | $3.6M | 270k | 13.20 | |
STAAR Surgical Company (STAA) | 2.3 | $3.4M | 205k | 16.80 | |
Novadaq Technologies | 2.3 | $3.4M | 203k | 16.48 | |
Techne Corporation | 2.2 | $3.3M | 36k | 92.58 | |
Alkermes (ALKS) | 2.2 | $3.2M | 64k | 50.33 | |
Oxford Immunotec Global | 2.1 | $3.1M | 185k | 16.83 | |
Spectrum Pharmaceuticals | 2.0 | $3.0M | 368k | 8.13 | |
Quidel Corporation | 1.9 | $2.9M | 130k | 22.11 | |
NPS Pharmaceuticals | 1.9 | $2.8M | 84k | 33.05 | |
NxStage Medical | 1.8 | $2.7M | 186k | 14.37 | |
Celldex Therapeutics | 1.5 | $2.3M | 139k | 16.32 | |
D Fluidigm Corp Del (LAB) | 1.4 | $2.1M | 73k | 29.40 | |
GenMark Diagnostics | 1.4 | $2.0M | 150k | 13.53 | |
LeMaitre Vascular (LMAT) | 1.3 | $2.0M | 236k | 8.27 | |
Cepheid | 1.3 | $1.9M | 40k | 47.94 | |
Align Technology (ALGN) | 1.2 | $1.9M | 33k | 56.03 | |
Advisory Board Company | 1.2 | $1.8M | 35k | 51.85 | |
HealthStream (HSTM) | 1.2 | $1.8M | 74k | 24.30 | |
Sagent Pharmaceuticals | 1.2 | $1.8M | 69k | 25.85 | |
Sunopta (STKL) | 1.1 | $1.7M | 118k | 14.08 | |
Covidien | 1.1 | $1.6M | 18k | 90.21 | |
InterMune | 1.0 | $1.5M | 35k | 44.15 | |
Vertex Pharmaceuticals Incorporated (VRTX) | 1.0 | $1.5M | 16k | 94.71 | |
Endologix | 0.9 | $1.4M | 93k | 15.21 | |
BioMarin Pharmaceutical (BMRN) | 0.8 | $1.2M | 20k | 62.22 | |
AngioDynamics (ANGO) | 0.8 | $1.1M | 68k | 16.33 | |
Aratana Therapeutics | 0.6 | $815k | 52k | 15.60 | |
Cytokinetics (CYTK) | 0.5 | $772k | 162k | 4.78 | |
Synergetics USA | 0.5 | $717k | 231k | 3.10 | |
Forest Laboratories | 0.4 | $610k | 6.2k | 99.07 | |
Endo International (ENDPQ) | 0.4 | $571k | 8.2k | 69.97 | |
Novartis (NVS) | 0.4 | $550k | 6.1k | 90.61 | |
Mylan | 0.3 | $504k | 9.8k | 51.56 | |
WellPoint | 0.3 | $441k | 4.1k | 107.69 | |
Humana (HUM) | 0.3 | $452k | 3.5k | 127.68 | |
AstraZeneca (AZN) | 0.3 | $422k | 5.7k | 74.30 | |
Aetna | 0.3 | $423k | 5.2k | 81.11 | |
St. Jude Medical | 0.3 | $419k | 6.1k | 69.20 | |
Johnson & Johnson (JNJ) | 0.3 | $400k | 3.8k | 104.71 | |
Bristol Myers Squibb (BMY) | 0.3 | $402k | 8.3k | 48.49 | |
Merck & Co (MRK) | 0.3 | $382k | 6.6k | 57.79 | |
Celgene Corporation | 0.2 | $368k | 4.3k | 85.98 | |
Eli Lilly & Co. (LLY) | 0.2 | $342k | 5.5k | 62.24 | |
Steris Corporation | 0.2 | $339k | 6.3k | 53.55 | |
CareFusion Corporation | 0.2 | $343k | 7.7k | 44.37 | |
United Therapeutics Corporation (UTHR) | 0.2 | $338k | 3.8k | 88.48 | |
Becton, Dickinson and (BDX) | 0.2 | $331k | 2.8k | 118.43 | |
Pfizer (PFE) | 0.2 | $312k | 11k | 29.66 | |
Sanofi-Aventis SA (SNY) | 0.2 | $302k | 5.7k | 53.17 | |
Agilent Technologies Inc C ommon (A) | 0.2 | $294k | 5.1k | 57.42 | |
Myriad Genetics (MYGN) | 0.2 | $304k | 7.8k | 38.87 | |
Amgen (AMGN) | 0.2 | $276k | 2.3k | 118.45 | |
Community Health Systems (CYH) | 0.2 | $279k | 6.1k | 45.40 | |
Bio-Rad Laboratories (BIO) | 0.1 | $201k | 1.7k | 120.00 |